Skip to main content
. 2011 Dec 1;19(23):7168–7180. doi: 10.1016/j.bmc.2011.09.056

Figure 3.

Figure 3

FXR agonists that have been co-crystallized with human FXR and served for binding mode analysis and training compounds for structure-based pharmacophore model generation. The corresponding PDB code is given for each compound and chemical interactions are shown in 2D.